GlassScriptPhysician profile
Michael J Feldstein
NPI 1568799989
$3,348.38
in general payments reported to CMS, 2019-2025
14 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $53.62 · 2021: $689 · 2022: $769 · 2023: $346 · 2024: $55.33 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $710.65 | 2021-2025 | G7, Oxford, Persona |
| Stryker Corporation | $566.40 | 2021-2025 | Gamma |
| Medacta USA, INC. | $452.49 | 2021-2024 | Gmk Sphere, Gmk Revision |
| Orthalign INC | $327.78 | 2023-2025 | Orthalign Plus |
| Evolution Surgical, INC | $314.12 | 2024-2025 | |
| Depuy Synthes Sales INC. | $248.38 | 2019-2022 | |
| Medical Device Business Services, INC. | $240.87 | 2019-2025 | Attune, Velys, Attune |
| Becton, Dickinson and Company | $170.61 | 2022 | |
| Medtronic USA, INC. | $81.69 | 2019 | |
| Biocomposites INC | $53.62 | 2020 | |
| Ethicon US, LLC | $50.66 | 2025 | Stratafix, Dermabond |
| Smith+Nephew, INC. | $50.01 | 2022 | |
| Orthofix Medical, INC. | $44.85 | 2023-2025 | Physio-Stim, Galaxy Fixation Gemini, Galaxy Fixation System |
| Think Surgical, INC. | $36.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Feldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.